Eplasty. 2009 Sep 29;9:e42.
A qualitative and quantitative analysis of protein substitution in human burn wounds.
Eplasty
Hamid Joneidi-Jafari, Adrien Daigeler, Joerg Hauser, Hans-Ulrich Steinau, Walter Klatte, Ulrich Fischer, Marcus Lehnhardt
PMID: 19865469
PMCID: PMC2754910
Abstract
OBJECTIVE: In major burn wounds of more than 15% total burn surface area mediator-associated reactions lead to capillary leak resulting in critical condition. Little is known about the efficiency of protein substitution. We quantified and qualified the systemic and local protein loss in burn patients during protein substitution, comparing fresh frozen plasma and the human serum protein solution Biseko.
METHODS: In 40 patients suffering from second-degree burn wounds with the total burn surface area between 20% and 60%, immediately after admission a defined wound surface area was enclosed with in a wound chamber. Wound fluid and serum samples were collected in 8 hour intervals for 2 days. Samples were analyzed for total protein, albumin, immunoglobulins -A, -G, -M, clotting parameters, c-reactive protein, and white blood cells. Protein substitution started 24 hour posttrauma. In a randomized pattern, patients received equal volumes of fresh frozen plasma or Biseko.
RESULTS: Total protein and albumin accumulated in high concentrations in wound fluid. With beginning of fresh frozen plasma substitution on day 2 posttrauma, serum total protein (1.7 g-3.9 g) and albumin (1.3 g-3.4 g) concentrations increased. Substitution of Biseko resulted in a stronger increase (serum total protein 1.8 g to 4.5 g, albumin 0.9 g to 3.4 g). Wound fluid concentrations revealed similar change patterns. Immunoglobulins showed higher serum levels in the Biseko group. C-reactive protein and white blood cell values indicated a lower immunological reaction in the Biseko group.
CONCLUSIONS: Substitution of human protein solutions such as Biseko can result in significantly higher serum protein and albumin concentrations as well as lower infection parameters. Higher serum immunoglobulins could help to decrease potential immunodeficiency.
References
- World J Surg. 1992 Jan-Feb;16(1):53-6 - PubMed
- Acta Physiol Scand Suppl. 1979;463:111-22 - PubMed
- Crit Care Med. 1981 Jul;9(7):503-8 - PubMed
- Surgery. 1984 Feb;95(2):136-44 - PubMed
- Crit Care Med. 1983 Nov;11(11):839-50 - PubMed
- J Clin Anesth. 1992 Jan-Feb;4(1):4-10 - PubMed
- Burns. 2005 Mar;31(2):159-67 - PubMed
- J Trauma. 1979 Nov;19(11 Suppl):864-5 - PubMed
- Surg Gynecol Obstet. 1972 Aug;135(2):257-60 - PubMed
- J Trauma. 1986 Jan;26(1):34-9 - PubMed
- J Surg Res. 1980 Feb;28(2):110-7 - PubMed
- Intensive Care Med. 2004 Dec;30(12):2222-9 - PubMed
- Arch Surg. 1997 Feb;132(2):158-61 - PubMed
- Resuscitation. 1991 Apr;21(2-3):137-80 - PubMed
- Jpn J Clin Oncol. 2003 Jun;33(6):309-13 - PubMed
- Crit Care Med. 1999 Jan;27(1):34-5 - PubMed
- Am J Physiol. 1982 Nov;243(5):H803-9 - PubMed
- J Burn Care Rehabil. 1996 Sep-Oct;17(5):379-83 - PubMed
- Z Gastroenterol. 2001 Jun;39 Suppl 2:24-7 - PubMed
- World J Surg. 1992 Jan-Feb;16(1):30-6 - PubMed
- J Wound Care. 2005 Jun;14(6):256-8 - PubMed
- Am J Nephrol. 2003 Jan-Feb;23(1):55-60 - PubMed
- Eur J Anaesthesiol. 2003 Jun;20(6):429-42 - PubMed
- Circ Res. 1981 Nov;49(5):1173-80 - PubMed
- Burns. 1991 Dec;17(6):484-9 - PubMed
- J Clin Apher. 1987;3(3):185-90 - PubMed
- Arch Surg. 1972 Sep;105(3):477-82 - PubMed
- Transfus Apher Sci. 2004 Aug;31(1):67-73 - PubMed
- Shock. 1996 Jan;5(1):4-16 - PubMed
- Crit Care Med. 2003 Aug;31(8 Suppl):S502-11 - PubMed
- Crit Care Med. 2002 Nov;30(11 Suppl):S500-14 - PubMed
- J Indian Med Assoc. 1996 Apr;94(4):133-4 - PubMed
- Scand J Plast Reconstr Surg. 1979;13(1):29-38 - PubMed
- Transfus Apher Sci. 2006 Aug;35(1):83-90 - PubMed
Publication Types